Showing results (111-120 of 180) with videos related to
Sort By:
Pageof 18
Arthritis Care & Research|February 13, 2013
Modest association of joint hypermobility with disabling and limiting musculoskeletal pain: results from a large-scale general population-based surveyMatthew R Mulvey, Gary J Macfarlane, Marcus Beasley, et al.Arthritis Care & Research|May 5, 2012
Association of morbid obesity with disability in early inflammatory polyarthritis: results from the Norfolk Arthritis RegisterJ H Humphreys, S M M Verstappen, H Mirjafari, et al.The American Journal of Clinical Nutrition|August 10, 2005
Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective studyDorothy J Pattison, Deborah P M Symmons, Mark Lunt, et al.Annals of the Rheumatic Diseases|April 4, 2008
Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics RegisterM J Harrison, W G Dixon, K D Watson, et al.Rheumatology (Oxford, England)|August 24, 2018
Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics RegisterKaren M Fagerli, Lianne Kearsley-Fleet, Louise K Mercer, et al.Pain|May 29, 2002
Low back pain in schoolchildren: occurrence and characteristicsKath D Watson, Ann C Papageorgiou, Gareth T Jones, et al.Annals of the Rheumatic Diseases|March 5, 2011
Parity, time since last live birth and long-term functional outcome: a study of women participating in the Norfolk Arthritis RegisterE M Camacho, M Harrison, T M Farragher, et al.Rheumatology (Oxford, England)|August 24, 2016
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid ArthritisLucía Silva-Fernández, Mark Lunt, Lianne Kearsley-Fleet, et al.Arthritis Research & Therapy|March 21, 2018
Risk factors for oral methotrexate failure in patients with inflammatory polyarthritis: results from a UK prospective cohort studyJames Bluett, Jamie C Sergeant, Alex J MacGregor, et al.Rheumatology (Oxford, England)|October 3, 2017
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLucía Silva-Fernández, Diederik De Cock, Mark Lunt, et al.Pageof 18